HGF and cancer: Because higher levels of HGF, or more precisely higher levels of tcHGF and pMET, are considered to be associated with cancer progressions such as drug resistance, the non-invasive detection of tcHGF and pMET is expected to be important for the selection of therapeutic drugs.